Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating emapalumab in adults with hemophagocytic lymphohistiocytosis was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Emapalumab (emapalumab)

Snippet

Sponsor: Swedish Orphan Biovitrum | Conditions: Hemophagocytic Lymphohistiocytoses | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2023-10-06